Rick Doblin

Date: 2023-03-31 | Duration: 2h 52m

Episode Overview

Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), dives deep into the evolving landscape of psychedelic research and therapy. He shares personal reflections on his early experiences with psychedelics and how those shaped his lifelong mission to legitimize MDMA-assisted psychotherapy. Doblin highlights the groundbreaking Phase III clinical trials demonstrating MDMA’s effectiveness in treating PTSD, emphasizing the rigorous scientific process and the challenges of overcoming stigma. He also discusses the broader therapeutic potential of psychedelics for conditions like eating disorders, postpartum depression, and couples therapy, underscoring the importance of integrating these treatments responsibly within medical frameworks. The conversation explores the history and cultural context of psychedelics, including the impact of the war on drugs and media-driven misinformation. Doblin recounts stories of early psychedelic pioneers and the setbacks they faced, illustrating how public perception has shifted over time. He also touches on the global expansion of psychedelic research, mentioning efforts to bring treatments like ibogaine to new regions. Throughout, Doblin stresses the need for equitable access and public benefit models to ensure these medicines serve diverse communities rather than purely commercial interests. The episode offers a nuanced look at the intersection of science, policy, and healing in the psychedelic renaissance.

About Rick Doblin

Rick Doblin, Ph.D., is a pioneering advocate for psychedelic research and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). With a background in public policy and a Ph.D. in sociology and psychology, he has spearheaded groundbreaking clinical trials exploring the therapeutic potential of MDMA for PTSD and other mental health conditions. Doblin's work has not only contributed to shifting public perception around psychedelics but has also positioned MAPS at the forefront of a renaissance in psychedelic science, making him a captivating figure in discussions about mental health and consciousness. His insights into the intersection of psychedelics and healing continue to spark interest and debate, making him a compelling guest on platforms like the Joe Rogan Experience.

Key Moments

– Psychedelic Therapy
– MDMA Research
– Drug Policy Reform
– Neuroplasticity
– PTSD Treatment
– Clinical Trials
– Psychedelic Harm Reduction
– Psychedelic History
– Ibogaine
– Psychedelic Integration
– Mental Health
– Veteran Care
– FDA Approval Process
– Psychedelic Education
– Drug War Impact
– Psychedelic Neuroscience
– Public Benefit Corporations
– Psychedelic Legislation
– Addiction Treatment
– Psychedelic Safety
0:00:21 – Rick Doblin's early involvement with Joe Rogan Experience
0:03:35 – Discussion on government efficiency and draft resistance
0:06:01 – Supreme Court case on draft resistance and its implications
0:08:40 – Views on defending America and pacifism
0:12:12 – Psychedelics' role in grief and healing
0:15:11 – Understanding drug users and societal perceptions
0:18:01 – The default mode network and sense of self
0:19:45 – Rick Doblin's transformative psychedelic experience in 1985
0:23:08 – Community support and sharing psychedelic healing
0:25:51 – Legal status of psychedelics and drug war impact
0:28:48 – Neuroplasticity and psychedelic effects on the brain
0:31:13 – Collaboration with Sasha Shulgin and psychedelic pioneers
0:33:27 – Impact of Reagan-era drug policies on psychedelics
0:35:14 – Personal experience with Ibogaine and LSD
0:39:49 – How psychedelics can disrupt mental patterns
0:43:09 – Efforts to develop ibogaine into medicine
0:47:56 – Psychedelic harm reduction at Burning Man
0:51:51 – Dr. Carl Hart's role in MAPS and neuroscience
0:54:02 – Veteran suicides and the need for new treatments
1:00:49 – Police officers using psychedelics for trauma
1:06:47 – Growth and themes of psychedelic science conferences
1:08:05 – FDA approval process and pharma strategies
1:13:59 – Success of MAPS Phase III clinical trials
1:17:13 – Johns Hopkins psychedelic research funding
1:23:56 – Ecstasy Rising documentary and public perception
1:30:38 – Wade Davis studies on voodoo and psychedelics
1:32:28 – Good Friday experiment and LSD's therapeutic potential
1:36:29 – Long-term effects of psilocybin on participants
1:43:32 – Resistance to DMT experiences and mind control
1:46:29 – Media influence on drug perception and policy
1:50:11 – Educating children about drugs and psychedelics
1:54:08 – Psilocybin research in prisons
2:00:17 – Psychedelics' impact on crime and recidivism
2:07:58 – Projected timeline for psychedelic medicine approval
2:12:18 – Funding needs for FDA approval of MDMA therapy
2:27:10 – Expanding MDMA therapy to other mental health disorders
2:30:05 – Challenges of double-blind studies in psychedelic research
2:36:54 – Breakthrough therapy designation for MDMA in 2017
2:47:10 – Need for affordable psychedelic treatments outside medicine

Transcript Excerpt

Starting point is 00:00:00 The Joe Rogan Experience. Starting point is 00:00:21 You were there like one of the first days. Starting point is 00:01:02 Thank you. Starting point is 00:01:47 order to do that you have to be a pacifist and so I'm not a pacifist. I think there are sometimes Starting point is 00:02:43 thing. He said, the person that thinks the law is unjust and violates it Starting point is 00:03:13 My dad was a doctor. Starting point is 00:03:35 I think a lot of times we overestimate the efficiency of the government. Starting point is 00:04:22 And I later read there was about 60,000 people that never registered for the draft. But enough people were going in that they were able Starting point is 00:05:04 And we've had a fair amount of that. Starting point is 00:05:20 who was the person that released the Pentagon Papers. Starting point is 00:06:01 potentially the rest of his life, which is what the government was trying to do for him. Went all the way up to the Supreme Court and he won the case, Starting point is 00:06:55 If we had lost and I'm Jewish, I probably would have been killed along with others. Starting point is 00:07:57 and people coming back from all these various foreign conflicts, Starting point is 00:08:40 attacked, if America was to be attacked, he would defend it. It doesn't turn people again into pacifists necessarily in that same way. And there's something noble and honorable about Starting point is 00:09:15 who's the chair of the board of directors Starting point is 00:09:46 And so Governor Perry – there's people that I have never thought that I would find common ground with. Starting point is 00:10:40 that's what he cares about the most, but others, that these things can be helpful. So this idea of building bridges, there was one point in time, one of the most important Starting point is 00:11:37 And so at this Passover Seder, my wife and I got there late. Starting point is 00:12:12 and about how it can be helpful for grief and all. And...

More Episodes

Frequently asked about this episode

Who was the guest on Joe Rogan Experience #1964?

Rick Doblin was the guest on JRE #1964. This page includes the episode overview, topics discussed, and related resources.

What topics were discussed on JRE #1964?

On Joe Rogan Experience #1964 with Rick Doblin, topics include Psychedelic Therapy, MDMA Research, Drug Policy Reform, and Neuroplasticity.

Where can I read the transcript for JRE #1964?

The full searchable transcript for Joe Rogan Experience #1964 with Rick Doblin is available on this page, along with key topics and timestamps.